You are viewing the site in preview mode
Skip to main content
| |
Biologicals
|
Anti-TNF
|
|---|
|
Yes n*(%)
|
PRˆ (IC95%)
|
p‡
|
Yes n*(%)
|
PRˆ (IC95%)
|
p‡
|
|---|
|
Cardiovascular Comorbidities
|
Yes
|
276 (69.3)
|
1.147 (1.050–1.253)
|
0.003
|
148 (66.7)
|
1.060 (0.954–1.179)
|
0.292
|
|
No
|
122 (30.7)
|
0.775 (0.652–0.922)
|
74 (33.3)
|
0.898 (0.731–1.101)
|
|
Systemic Arterial Hypertension
|
Yes
|
219 (55)
|
1.169 (1.039–1.315)
|
0.011
|
116 (52.3)
|
1.059 (0.919–1.221)
|
0.436
|
|
No
|
179 (45)
|
0.850 (0.747–0.967)
|
106 (47.7)
|
0.942 (0.808–1.097)
|
|
Dyslipidemia
|
Yes
|
144 (36.2)
|
1.186 (1.000–1.407)
|
0.052
|
80 (36)
|
1.138 (0.932–1.390)
|
0.212
|
|
No
|
254 (63.8)
|
0.918 (0.841–1.003)
|
142 (64)
|
0.936 (0.840–1.043)
|
|
Diabetes Mellitus
|
Yes
|
65 (16.3)
|
1.161 (0.872–1.546)
|
0.308
|
31 (14)
|
0.925 (0.644–1.328)
|
0.670
|
|
No
|
333 (83.7)
|
0.974 (0.924–1.020)
|
191 (86)
|
1.013 (0.955–1.076)
|
|
Congestive Heart Failure
|
Yes
|
10 (2.5)
|
1.289 (0.578–2.874)
|
0.535
|
3 (1.4)
|
0.575 (0.173–1.911)
|
0.448
|
|
No
|
388 (97.5)
|
0.994 (0.976–1.013)
|
219 (98.6)
|
1.010 (0.992–1.029)
|
|
Cerebrovascular Disease
|
Yes
|
4 (1)
|
0.361 (0.124–1.048)
|
0.054
|
1 (0.5)
|
0.175 (0.024–1.289)
|
0.066
|
|
No
|
394 (99)
|
1.018 (1.002–1.035)
|
222 (99.5)
|
1.022 (1.008–1.036)
|
|
Acute Myocardial Infarction
|
Yes
|
12 (3)
|
4.330 (1.536–12.201)
|
0.002
|
3 (1.4)
|
0.863 (0.250–2.977)
|
1.000
|
|
No
|
386 (97)
|
0.977 (0.959–0.995)
|
219 (98.6)
|
1.002 (0.985–1.020)
|
|
Peripheral Vascular Disease
|
Yes
|
3 (0.8)
|
1.082 (0.260–4.505)
|
1.000
|
1 (0.5)
|
0.575 (0.071–4.652)
|
1.000
|
|
No
|
395 (99.2)
|
0.999 (0.989–1.010)
|
221 (99.5)
|
1.003 (0.993–1.014)
|
- *Absolute frequencies; ˆ Prevalence Ratio ‡ Significance level
